We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Expert Opinion / Cases · April 01, 2022

Treatment of Leptomeningeal Metastases From Triple-Negative Breast Cancer

Written by
L. Nicolas Gonzalez Castro MD, PhD


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Amir Anvari

    Apr 01, 2022

    My recommendation  FRIST WBRT  30 GY IN 10 FRACTION  then intrathecal chemotherapy with mtx +cytarabine  

  • Anastasiia Nechaeva

    Apr 09, 2022

    Whether ventriculoperitoneal shunt increases risks of malignant cells dissemination?

  • Jul 07, 2022

    Pending Moderator approval.

Further Reading